Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting pharmacokinetics, safety and tolerability of a single-dose belatacept in adolescent kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• belatacept (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Kidney Transplant | Phase 2 | Status: COMPLETED | Results posted: 2017-06-26